1995
DOI: 10.1099/0022-1317-76-8-1893
|View full text |Cite
|
Sign up to set email alerts
|

Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

1996
1996
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 32 publications
1
10
0
Order By: Relevance
“…This domain, SU2, is located in the V3 region of the SU glycoprotein, which has previously been shown to be sensitive to neutralizing antibodies, as assessed with laboratory-adapted strains during infection of CrFK fibroblasts (Lombardi et al, 1993;de Ronde et al, 1994) but not a lymphoid cell line (Lombardi et al, 1995). We confirm and extend these results in demonstrating that antibodies directed against this region also neutralize the infectivity of primary virus for a more natural cellular target, activated feline PBMC.…”
Section: Neutralization Of Primary and Laboratory-adapted Virussupporting
confidence: 77%
See 2 more Smart Citations
“…This domain, SU2, is located in the V3 region of the SU glycoprotein, which has previously been shown to be sensitive to neutralizing antibodies, as assessed with laboratory-adapted strains during infection of CrFK fibroblasts (Lombardi et al, 1993;de Ronde et al, 1994) but not a lymphoid cell line (Lombardi et al, 1995). We confirm and extend these results in demonstrating that antibodies directed against this region also neutralize the infectivity of primary virus for a more natural cellular target, activated feline PBMC.…”
Section: Neutralization Of Primary and Laboratory-adapted Virussupporting
confidence: 77%
“…Similar results were obtained with FL-4 cells (data not shown). The accessibility of this domain is likely to be only partial: of antibodies elicited by a V3 peptide, polyclonal feline antibodies but not monoclonal antibodies labelled intact infected cells (Lombardi et al, 1993(Lombardi et al, , 1995. Temperature did not appear to influence the apparent degree of epitope exposure, as incubation of FL-4 cells with primary antibody at 4 °C or 37 °C had little effect on fluorescence intensity (data not shown).…”
Section: Epitope Accessibility On the Oligomeric Envelope Complexmentioning
confidence: 92%
See 1 more Smart Citation
“…The env gene of FIV shows sequence diversities among different isolates that cluster in discrete segments known as variable (V) regions. Eight or possibly nine such V regions have been identified in FIV.3-6 In FIV Env glycoproteins three possible domains directly or indirectly involved in FIV neutralization have been described: two in the regions V4 and V5 of gp95, as shown by the fact that amino acid substitutions in these domains conferred resistance to virus neutralization,7" and the third in the V3 region spanning amino acidS 366C_C417 10,11 By the use of recombinant proteins or peptides, other antibody-binding sites have been mapped on SU and TM molecules. Pancino et al}2 by screening a random peptide library, identified five regions of the SU glycoprotein that were recognized by variable proportions of infected cat sera; one region appeared to be isolate specific while the others were more or less extensively broadly reactive.…”
Section: Introductionmentioning
confidence: 99%
“…FIV infection results in the synthesis of neutralizing antibodies that are targeted to various envelope domains with variable loop 3 and the carboxy terminus of envelope consisting of major antigenic sites (de Ronde et al 1994;Lombardi et al 1995;Richardson et al 1996). As with HIV-1, the cross-reactivity of sera for various FIV strains is highly variable (de Ronde et al 1994;Del Mauro et al 1998;Hohdatsu et al 1997;Osborne et al 1994;Richardson et al 1996) and specific mutations can confer resistance (Siebelink et al 1995).…”
Section: Fiv: a Lentivirus Similar To Hivmentioning
confidence: 99%